SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0001032210-02-000530
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
6
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-KSB d10ksb.htm 10KSB 439498
3 RESTATED CERTIFICATE OF INCORPORATION dex3a.txt EX-3.(A) 186396
4 COMPOSITE BYLAWS OF THE COMPANY dex3b.txt EX-3.(B) 32582
5 SERIES C PREFERRED STOCK SUBSCR. & EMPLMT. AGREE. dex10b.txt EX-10.(B) 63449
6 SUBSIDIARIES OF OXIS INTERNATIONAL, INC. dex21a.txt EX-21.(A) 827
7 INDEPENDENT AUDITOR'S CONSENT dex23b.txt EX-23.(B) 734
  Complete submission text file 0001032210-02-000530.txt   725818
Mailing Address 6040 N CUTTER CIRCLE STE 317 PORTLAND OR 97217
Business Address 6040 N CUTTER CIRCLE STE 317 PORTLAND OR 97217 5032833911
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 000-08092 | Film No.: 02595239
SIC: 2834 Pharmaceutical Preparations